Aida Pharmaceuticals, Inc.
Aida Pharmaceuticals, Inc. (AIDA) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
aida · pe ratio · data through Dec 31, 2007
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Aida Pharmaceuticals, Inc. (AIDA) measures how much investors pay for each dollar of the company's trailing earnings. AIDA's current PE ratio of 0.00x is calculated by dividing its stock price of $0.00 by its TTM earnings per share of $0.10. −100.0% discount vs 5Y avg 19.9x
Source: FMP · /ratios-ttm · /analyst-estimates · 2007-12-31
PE Ratio History
2004 – 2007 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 4 fiscal years · Front-end computedMinQ1 · 25%20.4x
MedianQ3 · 75%32.1x
Max
At 0.00x, AIDA's current P/E is lower than in 0% of its annual fiscal year readings over the past 4 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Aida Pharmaceuticals, Inc.You AIDA | $0M | 0.00x | — | $0.10 |
 Bloomios, Inc. BLMS | $0M | N/A | — | -$1.04 |
 Better Therapeutics, Inc. BTTX | $0M | N/A | — | -$1.69 |
 CanaQuest Medical Corp. CANQF | $0M | N/A | — | -$0.09 |
 CEN Biotech, Inc. CENBF | $0M | N/A | — | -$0.02 |
 MJ Holdings, Inc. MJNE | $0M | N/A | — | -$0.07 |
 Panacos Pharmaceuticals, Inc. PANC | $0M | N/A | — | -$0.70 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2007-12-31Latest FY2007 | 11.14x | $0.10 | -65.3% | |
2006-12-31 FY2006 | 32.13x | $0.06 | +8.6% | |
2005-12-31 FY2005 | 29.59x | $0.06 | +331.2% | |
2004-12-31 FY2004 | 6.86x | $0.07 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Aida Pharmaceuticals, Inc. (AIDA) measures how much investors pay for each dollar of the company's trailing earnings. AIDA's current PE ratio of 0.00x is calculated by dividing its stock price of $0.00 by its TTM earnings per share of $0.10.
Frequently asked questions
AIDA pe ratio · 6 questionsAIDA's current PE ratio is 0.00x as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of $0.10. Data sourced from Financial Modeling Prep via AIDA's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Aida Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09